The effect of cyclosporin (CYA), FK 506, and mycophenolate mofetil (MP
M) on tumor growth was investigated using syngeneic mouse colon carcin
oma 38. Mice were laparotomized and the tumor cells were injected into
the portal vein to establish liver metastasis. The animals were group
ed as follows: groups A-1, B-1, and C-1 were given CyA [15 mg/kg body
weight (BW)], FK 506 (0.15 mg/kg BW), and MPM (100 mg/kg BW), respecti
vely, 30 min before tumor inoculation and daily for 5 days by gavage;
groups A-2, B-2, and C-2 were given CyA (30 mg/kg BW), FK 506 (0.3 mg/
kg BW), and MPM (200 mg/kg BW), respectively, with the same dose timin
g; and groups A-3, B-3, and C-3 received CyA (30 mg/kg BW), FK 506 (0.
3 mg/kg BW), and MPM (200 mg/kg BW), respectively, on the 7th post-tum
or inoculation day and on the following 5 days. The mean tumor diamete
r in groups A-1 and A-2 was greater than that in the control group and
in groups C-1 and C-2 at 3 weeks (P < 0.05). The mean tumor numbers i
n groups A-1 and A-2 were greater than those in the control group and
in groups C-1 and C-2 at 4 weeks (P < 0.05). With in vitro MTT assay,
all three drugs acted cytostatically on tumor cells with a higher conc
entration (10(-6)-10(-4) mol/l), while no cytostatic effect was noted
with CyA at a lower concentration (10(-9)-10(-7) mol/l). Labeling inde
xes (%) by bromodeoxyuridine (BrdUrd) immunohistochemistry in groups A
-1, A-2, and B-1 were significantly greater than those in the control
group and in groups C-1 and C-2 (P < 0.05). Although the mechanism of
cytoproliferative action of CyA and FK 506 is not well understood, a d
ecrease in immunosurveillance capability by natural kill cells due to
suppression of interleukin-2, their direct action as growth factors, a
nd/or enhanced tumor cell adhesion can be considered.